Cargando…
Commissioning and clinical implementation of the first commercial independent Monte Carlo 3D dose calculation to replace CyberKnife M6™ patient‐specific QA measurements
PURPOSE: To report on the commissioning and clinical validation of the first commercially available independent Monte Carlo (MC) three‐dimensional (3D) dose calculation for CyberKnife robotic radiosurgery system® (Accuray, Sunnyvale, CA). METHODS: The independent dose calculation (IDC) by SciMoCa® (...
Autores principales: | Milder, Maaike T. W., Alber, Markus, Söhn, Matthias, Hoogeman, Mischa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700940/ https://www.ncbi.nlm.nih.gov/pubmed/33103343 http://dx.doi.org/10.1002/acm2.13046 |
Ejemplares similares
-
Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
por: Mackeprang, P.-H., et al.
Publicado: (2019) -
Validation of Monte Carlo dose calculation algorithm for CyberKnife multileaf collimator
por: Gondré, Maude, et al.
Publicado: (2021) -
Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Spine Lesions Treated With CyberKnife
por: Li, Jun, et al.
Publicado: (2022) -
Clinical implications of adopting Monte Carlo treatment planning for CyberKnife
por: Sharma, Subhash C., et al.
Publicado: (2010) -
Commissioning and acceptance testing of a CyberKnife linear accelerator
por: Sharma, Subhash C., et al.
Publicado: (2007)